Week of September 12, 2023 | Vol. 12, Issue 36

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

Investment Banking

Strategic Capital

Research


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

jjohnson@bourne-partners.com

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

595330 image
1686840562811 image
1200px-J_P_Morgan_Logo_2008_1 image

Nicholas Hall’s North American CHC Conference

September 13-14, 2023 - Morristown, NJ

Contract Pharma 2023

September 21-22, 2023 - New Brunswick, NJ

Bourne Partners Annual CEO Summit 2023

Invitation Only

October 4, 2023 - Charlotte, NC

CPHI Barcelona

October 24-26, 2023 - Barcelona, Spain

Supply Side West 2023

October 23-27, 2023 - Las Vegas, NV

JP Morgan Healthcare Conference 2024

January 8-11, 2024 - San Francisco, CA

Bourne Partners Proudly Announces Speaker for Annual CEO Summit: Patrick Walsh


Mr. Walsh has been a CEO and Director of multiple successful growth organizations and has served as Chairman, Non-Executive Chairman, and on audit, nominating, and compensation committees of private equity backed and publicly traded corporations. He has considerable experience in corporate strategy, mergers, and acquisitions, and creating high growth opportunities in the contract service, pharmaceutical or specialty pharma sectors. Mr. Walsh also has extensive experience directing pharmaceutical manufacturing and lab operations on a global scale in fill finish, API, specialty pharmaceutical, formulation, manufacturing, and analytical contract development organizations. 


This intimate gathering is limited to CEOs only. Should you have interest in participating, kindly let your Bourne Partners contact know and we will assist with an invitation. If you are planning to attend, please reach out to Jennifer Buchanan to confirm your spot if you haven't already done so.

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

4 transactions totaling $219 million


Supplies, Equipment & Services

27 transactions totaling $1.5 billion


Healthcare Facilities & Distributors

4 transactions


Healthcare IT & Managed Care

7 transactions totaling $1.9 billion

Private Placements

Pharma & Biotech

25 transactions totaling $1.0 billion


Supplies, Equipment & Services

20 transactions totaling $287 million


Healthcare Facilities & Distributors

1 transaction


Healthcare IT & Managed Care

8 transactions totaling $183 million

Public Offerings

Pharma & Biotech

10 transactions totaling $1.3 billion


Supplies, Equipment & Services

10 transactions totaling $33 million


Healthcare Facilities & Distributors

0 transactions


Healthcare IT & Managed Care

0 transactions

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs


Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical Manufacturer 


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry

US FDA- Sep 2023

Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy

Recipharm - Sep 5, 2023

Singapore's HiRO snaps up US oncology CRO Courante

Fierce Biotech - Sep 6, 2023

Signal: Pharma giant Novartis to spin-off generics brand

Pharmaceutical Technology - Sep 6, 2023

Paige taps Microsoft to help train cancer-spotting AI on massive image database

Fierce Biotech - Sep 7, 2023

Societal CDMO Secures Project Expansion Agreements with Several Existing Customers

Societal CDMO - Sep 7, 2023

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Fierce Pharma - Sep 7, 2023

AstraZeneca hopes to make clinical trial operations carbon-negative by 2030

Pharmaceutical Technology - Sep 7, 2023

Permira takes CRO Ergomed private in £703M buyout deal

Fierce Biotech - Sep 7, 2023

Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics

PR Newswire - Sep 8, 2023

AstraZeneca converges with Verge's AI tech in $42M neurodegenerative disease R&D pact

Fierce Biotech - Sep 8, 2023

Calibrating cold chain systems for cell and gene therapies in a post-pandemic world

Pharmaceutical Technology - Sep 11, 2023

TANNER NEWS

Linkedin  

TannerCares x Hearts and Hands Food Pantry work towards a stronger, more caring community


Tanner recently joined hands with Hearts and Hands Food Pantry to give back to our community. Our team hosted a food drive, with TannerCares providing a monetary donation to match our team's generous contributions. Both our organizations share a deep commitment to making a positive impact, and together, we're working towards a stronger, more caring community.